TAS-115

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

TAS-115 is an investigational medication currently being studied in clinical trials. It is being evaluated for its potential use in treating certain types of cancer, including colorectal cancer. The trials are in early phases (Phase 1), meaning researchers are primarily looking at its safety and determining the best way to give it. TAS-115 is being tested alone and in combination with other cancer treatments, such as chemotherapy agents (like 5-Fluorouracil, Gemcitabine, Nab-Paclitaxel) and targeted therapies (like Bevacizumab, Ramucirumab). Some trials are specifically looking at patients whose tumors have certain genetic changes (mutations or expression levels) like EGFR, KRAS, MET, NRAS, PD-L1, or VEGF mutations. As an investigational drug, TAS-115 is not yet approved for use in colorectal cancer or any other condition.

Mechanism of Action

The specific way TAS-115 works (its mechanism of action) is still under investigation in clinical trials. It is being studied to see how it affects cancer cells and the body's response to it. Researchers are working to understand its molecular target and how it might interfere with tumor growth or spread.

Side Effects

Because TAS-115 is an investigational drug in early-phase trials The full range of potential side effects is still being evaluated. The primary focus of Phase 1 trials is to assess safety and tolerability. Information about specific side effects observed in these trials is limited and not yet fully characterized. As more data becomes available from ongoing clinical studies A clearer picture of the potential side effects will emerge.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT04999761 Phase 1
Recruiting
AB122 Platform Study
Japan

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.